Bolt Biotherapeutics's total assets for Q1 2026 were $48.03M, a decrease of -15.37% from the previous quarter. BOLT total liabilities were $28.20M for the fiscal quarter, a -6.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.